Net Product Sales of $2.95B in Q117; Increased 18 YY REVLIMIDÂ Net Product Sales of $1.9B in Q117; Increased 20 YY Raising 2017 EPS Guidance Positive phase II STEPSTONE data with ozanimod in Crohns dis...
↧